RxDoctor Payments Data

Ashley Starnes

Family · Annapolis, MONPI 1588113435

Payments from drug & device makers

$256in general payments, 2019–2025

Across 13 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Indivior Inc.$44
  • Mannkind Corporation$43
  • Braeburn Inc.$39
  • Boston Scientific$30
  • Organon$21
  • Apria Healthcare LLC$21
  • plus $59 from 4 others

What the payments were for

  • Food & beverage$21383%
  • Education$4317%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$256 in reported general payments places this provider in the 40th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$1,375
Medicare patients
33
Services billed
118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$34,717
TrulicityDulaglutide24$23,564
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$20,610
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl98$19,777
JanuviaSitagliptin Phosphate13$13,108
JardianceEmpagliflozin14$10,661
Breo ElliptaFluticasone/Vilanterol25$9,887
VascepaIcosapent Ethyl23$9,487
EliquisApixaban11$8,942
Tresiba Flextouch U-100Insulin Degludec11$8,575
SuboxoneBuprenorphine Hcl/Naloxone Hcl14$8,170
Combivent RespimatIpratropium/Albuterol Sulfate15$7,219
Incruse ElliptaUmeclidinium Bromide19$6,479
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$6,310
Albuterol Sulfate HfaAlbuterol Sulfate103$4,081

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$12$13,10813 claims
Indivior Inc.Suboxone$44$8,17014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,812 family providers in Missouri.

Other family in Annapolis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →